The Gross Margin of JW (Cayman) Therapeutics Co Ltd (2126.HK) is 48.87%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2024-12-31 | 48.87% |
2023-12-31 | 50.74% |
2022-12-31 | 40.33% |
2021-12-31 | 29.37% |
2020-12-31 | 29.37% |